🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 04/09/1996 | 0,1908 USD |
| 06/06/1996 | 0,1622 USD |
| 06/03/1996 | 0,1622 USD |
| 06/12/1995 | 0,1622 USD |
| 05/09/1995 | 0,1622 USD |
| 02/06/1995 | 0,1431 USD |
| 03/03/1995 | 0,1431 USD |
| 02/12/1994 | 0,1431 USD |
| 02/09/1994 | 0,1431 USD |
| 02/06/1994 | 0,1336 USD |
| 02/03/1994 | 0,1336 USD |
| 02/12/1993 | 0,1336 USD |
| 02/09/1993 | 0,1336 USD |
| 02/06/1993 | 0,1193 USD |
| 02/03/1993 | 0,1193 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 07/08/2007 | 48,55 | 49,95 | 48,47 | 49,27 | +0,55% | 3,05% | 14.165.187 |
| 06/08/2007 | 48,86 | 49,22 | 48,15 | 49,00 | +2,11% | 2,19% | 13.726.494 |
| 03/08/2007 | 49,29 | 49,35 | 47,94 | 47,99 | -2,61% | 2,86% | 11.747.137 |
| 02/08/2007 | 49,07 | 49,74 | 48,49 | 49,27 | +1,22% | 2,55% | 13.222.721 |
| 01/08/2007 | 47,35 | 48,92 | 47,30 | 48,68 | +2,76% | 3,43% | 17.262.656 |
| 31/07/2007 | 48,00 | 48,15 | 47,23 | 47,38 | -0,94% | 1,91% | 15.072.546 |
| 30/07/2007 | 48,06 | 48,06 | 47,19 | 47,82 | +0,00% | 1,83% | 12.122.740 |
| 27/07/2007 | 49,59 | 49,78 | 47,78 | 47,82 | -3,56% | 4,04% | 17.475.190 |
| 26/07/2007 | 50,57 | 51,27 | 49,13 | 49,59 | -2,64% | 4,23% | 22.877.316 |
| 25/07/2007 | 49,95 | 51,22 | 49,81 | 50,94 | +3,21% | 2,83% | 19.905.607 |
| 24/07/2007 | 50,52 | 51,35 | 49,17 | 49,35 | -1,17% | 4,31% | 17.923.630 |
| 23/07/2007 | 49,18 | 50,91 | 48,84 | 49,93 | +6,75% | 4,21% | 41.864.561 |
| 20/07/2007 | 47,28 | 47,71 | 46,57 | 46,77 | -0,65% | 2,40% | 14.354.142 |
| 19/07/2007 | 47,69 | 47,77 | 46,87 | 47,08 | -1,20% | 1,88% | 11.842.819 |
| 18/07/2007 | 47,71 | 48,07 | 47,07 | 47,65 | -0,66% | 2,10% | 11.154.598 |
| 17/07/2007 | 48,33 | 48,76 | 47,83 | 47,97 | -1,10% | 1,91% | 8.095.381 |
| 16/07/2007 | 48,20 | 48,53 | 47,89 | 48,50 | -0,04% | 1,33% | 8.825.942 |
| 13/07/2007 | 48,23 | 48,79 | 48,16 | 48,52 | +0,16% | 1,31% | 10.625.567 |
| 12/07/2007 | 46,95 | 48,54 | 46,66 | 48,44 | +3,82% | 4,00% | 17.484.308 |
| 11/07/2007 | 46,28 | 46,90 | 46,21 | 46,66 | +0,49% | 1,48% | 14.496.250 |
| 10/07/2007 | 46,77 | 47,26 | 46,37 | 46,43 | -1,54% | 1,90% | 12.887.256 |
| 09/07/2007 | 47,23 | 47,30 | 46,79 | 47,16 | -0,08% | 1,07% | 9.621.059 |
| 06/07/2007 | 47,61 | 47,68 | 46,63 | 47,19 | -0,72% | 2,20% | 9.678.909 |
| 05/07/2007 | 47,42 | 47,61 | 47,10 | 47,54 | -0,02% | 1,07% | 8.491.106 |
| 03/07/2007 | 47,66 | 47,96 | 47,31 | 47,55 | +0,52% | 1,36% | 5.454.211 |
| 02/07/2007 | 47,62 | 48,00 | 46,97 | 47,30 | -0,46% | 2,16% | 13.771.768 |
| 29/06/2007 | 48,62 | 48,62 | 47,20 | 47,52 | -1,35% | 2,90% | 15.128.404 |
| 28/06/2007 | 48,27 | 48,76 | 47,98 | 48,17 | +0,30% | 1,62% | 13.367.659 |
| 27/06/2007 | 46,83 | 48,38 | 46,54 | 48,02 | +2,46% | 3,93% | 19.820.195 |
| 26/06/2007 | 46,21 | 47,46 | 46,18 | 46,87 | +1,61% | 2,77% | 16.883.385 |